COGN 201
Alternative Names: COGN-201Latest Information Update: 28 Mar 2024
At a glance
- Originator Cognigenics
- Class Gene therapies; Neuropsychotherapeutics; RNA
- Mechanism of Action Gene expression inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Anxiety disorders; Cognition disorders